Monitoring carbon dioxide levels in patients on VA-ECMO
Validation of Continuously Determined Transcutaneous Carbon Dioxide Partial Pressures in Patients Supported with Veno-arterial Extracorporeal Membrane Oxygenation
This study tests if a new way of measuring carbon dioxide levels on the skin can give better results than regular blood tests for patients on VA-ECMO.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna) |
| Trial ID | NCT04445909 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of continuous transcutaneous carbon dioxide monitoring in patients receiving veno-arterial extracorporeal membrane oxygenation (VA-ECMO). It aims to compare non-invasive transcutaneous carbon dioxide measurements with traditional blood gas analysis to improve monitoring accuracy. Participants will have their carbon dioxide levels measured simultaneously through various methods over a four-hour observation period. The study also records additional physiological parameters to assess the overall condition of the patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with low cardiac output requiring VA-ECMO support.
Not a fit: Patients under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the monitoring of carbon dioxide levels in VA-ECMO patients, potentially improving patient outcomes by preventing harmful fluctuations.
How similar studies have performed: While this approach is innovative, similar studies have not been widely reported, indicating a novel exploration in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Low cardiac output requiring VA-ECMO support. Exclusion Criteria: * Age \< 18 years
Where this trial is running
Vienna
- Medical University of Vienna — Vienna, Austria (Recruiting)
Study contacts
- Principal investigator: Martin Dworschak, MD, MBA — Medical University of Vienna
- Study coordinator: Martin Dworschak, MD, MBA
- Email: martin.dworschak@meduniwien.ac.at
- Phone: +43-1-40400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.